NovoCure's Other Non-Current Assets rose 154.61% to $12.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.4 million, marking a year-over-year increase of 154.61%. This contributed to the annual value of $14.6 million for FY2024, which is 425.05% up from last year.
As of Q3 2025, NovoCure's Other Non-Current Assets stood at $12.4 million, which was up 154.61% from $15.6 million recorded in Q2 2025.
NovoCure's 5-year Other Non-Current Assets high stood at $15.6 million for Q2 2025, and its period low was $10.6 million during Q2 2021.
In the last 5 years, NovoCure's Other Non-Current Assets had a median value of $12.1 million in 2021 and averaged $12.5 million.
Per our database at Business Quant, NovoCure's Other Non-Current Assets soared by 12363.18% in 2021 and then crashed by 1722.48% in 2024.
Quarter analysis of 5 years shows NovoCure's Other Non-Current Assets stood at $12.1 million in 2021, then dropped by 7.65% to $11.2 million in 2022, then increased by 25.63% to $14.0 million in 2023, then rose by 4.25% to $14.6 million in 2024, then fell by 15.08% to $12.4 million in 2025.
Its Other Non-Current Assets was $12.4 million in Q3 2025, compared to $15.6 million in Q2 2025 and $14.5 million in Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value